|
시장보고서
상품코드
2055249
집단 선별검사 시장 : 제품 유형별, 용도별, 성별, 연령층별, 제공 형태별, 최종사용자별, 지역별Population Screening Market, By Product Type, By Application Area, By Gender, By Age Group, By Delivery Mode, By End User,By Geography |
||||||
집단 선별검사 시장은 2026년 275억 7,000만 달러로 추정되며, 2033년까지 404억 2,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 5.6%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 275억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 5.60% | 2033년 시장 규모 예측 : | 404억 2,000만 달러 |
세계 인구 선별 검사 시장은 질병을 조기에 발견하고 예방하는 것을 목표로 하는 의료 분야의 중요한 한 축으로 부상하고 있습니다. 인구 기반 선별검사는 무증상자를 대상으로 체계적인 검사를 실시하여 특정 질환 발병 위험이 있는 사람들을 파악함으로써, 적시적인 개입과 건강 상태의 개선을 가능하게 하는 것입니다. 전 세계가 만성 질환 증가와 의료비 급등이라는 과제에 직면한 가운데, 효과적인 집단 검진 프로그램의 중요성은 아무리 강조해도 지나치지 않습니다. 이 시장에는 유전자 검사, 암 검진, 심혈관 질환 검진, 감염증 검진 등 다양한 검진이 포함됩니다. 인공지능과 유전체학의 융합과 같은 기술 발전에 힘입어, 집단 검진 시장은 향후 몇 년 동안 눈부신 성장과 혁신을 이룰 것으로 전망됩니다.
시장 역학:
세계 집단 검진 시장은 만성 질환 유병률 증가, 질병 조기 발견에 대한 인식 제고, 보건 의료를 장려하는 정부의 이니셔티브 등 여러 요인에 힘입어 성장하고 있습니다. 암, 당뇨병, 심혈관 질환 등 질병으로 인한 부담이 커짐에 따라, 위험군에 속하는 개인을 선별하고 적시에 개입할 수 있는 효과적인 선별 검진 프로그램의 필요성이 대두되고 있습니다. 또한, 액체 생검, 차세대 염기서열 분석, AI를 활용한 영상 분석과 같은 선별 검사 기술의 발전으로 인해 검사의 정확도와 효율성이 향상되어 시장 성장이 더욱 가속화될 것으로 예측됩니다. 그러나 시장에는 선별 검사에 따른 고비용, 특정 지역의 의료 서비스 접근성 제한, 위양성 결과나 과잉 진단에 대한 우려 등 몇 가지 제약 사항도 존재합니다. 또한, 유전자 스크리닝 및 데이터 개인정보 보호와 관련된 규제상의 과제와 윤리적 고려 사항이 시장 성장의 걸림돌이 될 수 있습니다. 이러한 과제가 있음에도 불구하고, 집단 검진 시장은 이해관계자들에게 큰 성장 기회를 제공합니다. 원격 의료 및 원격 모니터링 솔루션의 도입 확대는 특히 의료 서비스가 충분히 제공되지 않는 지역에서 선별 검진 프로그램의 적용 범위를 넓힐 수 있는 잠재력을 지니고 있습니다. 또한, 집단 선별 검사를 약물유전체학이나 위험군 분류와 같은 맞춤형 의료 접근법과 통합함으로써, 대상 집단을 좁혀 중재할 수 있게 되어 환자의 예후를 최적화할 수 있습니다. 전 세계 의료 시스템이 예방 의료와 비용 효율성에 주력하는 가운데, 집단 검진 시장은 향후 몇 년 동안 상당한 성장과 혁신을 이룰 것으로 예측됩니다.
본 조사의 주요 특징:
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 집단 검진 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계 인구 선별 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업 및 금융 분석가를 포함한 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 세계 집단 선별검사 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 집단 선별검사 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 집단 선별검사 시장 : 용도별, 2021년-2033년
제6장 세계의 집단 선별검사 시장 : 성별, 2021년-2033년
제7장 세계의 집단 선별검사 시장 : 연령층별, 2021년-2033년
제8장 세계의 집단 선별검사 시장 : 유통 모드별, 2021년-2033년
제9장 세계의 집단 선별검사 시장 : 최종사용자별, 2021년-2033년
제10장 세계의 집단 선별검사 시장 : 지역별, 2021년-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
LSH 26.06.23Population Screening Market is estimated to be valued at USD 27.57 Bn in 2026 and is expected to reach USD 40.42 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 27.57 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.60% | 2033 Value Projection: | USD 40.42 Bn |
The global population screening market has emerged as a crucial aspect of preventive healthcare, aiming to detect and prevent diseases at an early stage. Population screening involves the systematic testing of asymptomatic individuals to identify those at risk of developing specific conditions, enabling timely intervention and improved health outcomes. As the world faces an increasing burden of chronic diseases and rising healthcare costs, the importance of effective population screening programs cannot be overstated. This market encompasses various screening tests, including genetic screening, cancer screening, cardiovascular screening, and infectious disease screening, among others. With advancements in technology, such as the integration of artificial intelligence and genomics, the population screening market is poised for significant growth and innovation in the coming years.
Market Dynamics:
The global population screening market is driven by several factors, including the rising prevalence of chronic diseases, increasing awareness about early disease detection, and government initiatives to promote preventive healthcare. The growing burden of diseases such as cancer, diabetes, and cardiovascular disorders has heightened the need for effective screening programs to identify at-risk individuals and enable timely intervention. Moreover, advancements in screening technologies, such as liquid biopsy, next-generation sequencing, and AI-powered imaging analysis, are expected to enhance the accuracy and efficiency of screening tests, further driving market growth. However, the market also faces certain restraints, such as high costs associated with screening tests, limited access to healthcare services in certain regions, and concerns regarding false-positive results and overdiagnosis. Additionally, regulatory challenges and ethical considerations surrounding genetic screening and data privacy may pose obstacles to market growth. Despite these challenges, the population screening market presents significant opportunities for stakeholders. The increasing adoption of telehealth and remote monitoring solutions has the potential to expand the reach of screening programs, particularly in underserved areas. Furthermore, the integration of population screening with personalized medicine approaches, such as pharmacogenomics and risk stratification, can enable targeted interventions and optimize patient outcomes. As healthcare systems worldwide focus on preventive care and cost-effectiveness, the population screening market is expected to witness substantial growth and innovation in the coming years.
Key Features of the Study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global population screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, Hologic, PerkinElmer, Illumina, Cepheid, Genomic Health, Agilent Technologies, Ortho Clinical Diagnostics, Becton, Dickinson and Company, and Beckman Coulter.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global population screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global population screening market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Hardware Equipment
- Diagnostic Devices
- Sample Collection Devices
- Imaging Equipment
- Testing or Laboratory Services
- Laboratory Testing Kits
- Point-of-Care Testing
- Blood and Urine Testing Services
- Analytics or Interpretation
- Software Solutions for Data Analysis
- Interpretation Services
- Reporting Tools
- Others
- Application Area Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Cardiology
- Immunology
- Neurology
- Genetics and Genomics
- Endocrinology and Metabolism
- Infectious Diseases
- Reproductive and Maternal Health
- Pediatrics and Neonatology
- Psychiatry and Mental Health
- Hematology
- Gastroenterology
- Nephrology
- Gender Insights (Revenue, USD Bn, 2021 - 2033)
- Male
- Female
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric Population
- Adult Population
- Elderly Population
- Delivery Mode Insights (Revenue, USD Bn, 2021 - 2033)
- Onsite/Facility-Based Screening
- Remote/Telehealth Screening
- Mobile Screening Units
- Self-Testing/Home-Based
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
- Government and Public Health Agencies
- Specialty Clinics
- Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- QIAGEN
- Hologic
- PerkinElmer
- Illumina
- Cepheid
- Genomic Health
- Agilent Technologies
- Ortho Clinical Diagnostics
- Becton, Dickinson and Company
- Beckman Coulter
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Population Screening Market, By Product Type
- Global Population Screening Market, By Application Area
- Global Population Screening Market, By Gender
- Global Population Screening Market, By Age Group
- Global Population Screening Market, By Delivery Mode
- Global Population Screening Market, By End User
- Global Population Screening Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Population Screening Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hardware Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Devices
- Sample Collection Devices
- Imaging Equipment
- Testing or Laboratory Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Laboratory Testing Kits
- Point-of-Care Testing
- Blood and Urine Testing Services
- Analytics or Interpretation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Software Solutions for Data Analysis
- Interpretation Services
- Reporting Tools
- Others
5. Global Population Screening Market, By Application Area, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Genetics and Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Endocrinology and Metabolism
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Reproductive and Maternal Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pediatrics and Neonatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Psychiatry and Mental Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nephrology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Population Screening Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Population Screening Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Elderly Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Population Screening Market, By Delivery Mode, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Onsite/Facility-Based Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Remote/Telehealth Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Mobile Screening Units
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Self-Testing/Home-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Population Screening Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Government and Public Health Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Population Screening Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cepheid
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Genomic Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ortho Clinical Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Beckman Coulter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
